Dr. Eric Lander: A principal leader of the Human Genome Project, Lander’s work at the Broad Institute has been instrumental in exploring genomic foundations of human health and disease.
Dr. Francis Collins: As the Director of the National Institutes of Health (NIH) and a leader in the Human Genome Project, Collins has played a crucial role in pushing genomics to the forefront of medicine.
Dr. Anne Wojcicki: Co-founder and CEO of 23andMe, Wojcicki has popularized direct-to-consumer genetic testing, offering insights into both ancestry and health.
Dr. George Church: A professor at Harvard and MIT, Church’s work spans genomics, gene editing, and gene sequencing. He’s renowned for his advancements in CRISPR and next-generation sequencing.
Dr. Jennifer Doudna: A Nobel laureate recognized for her pioneering work in developing the CRISPR-Cas9 gene-editing system, Doudna’s research holds immense promise for personalized medicine.
Dr. Craig Venter: Known for sequencing the first human genome, Venter’s endeavors at the J. Craig Venter Institute and Human Longevity, Inc. focus on harnessing genomics for individualized health insights.
Dr. Leroy Hood: A leading voice in systems biology, Hood’s work at the Institute for Systems Biology emphasizes P4 medicine – predictive, preventive, personalized, and participatory.
Dr. Atul Butte: As the director of the Institute for Computational Health Sciences at UCSF, Butte focuses on transforming billions of molecular, clinical, and epidemiological data points into diagnostics, therapeutics, and insights.
Dr. Elaine Mardis: Co-executive director of the Institute for Genomic Medicine at Nationwide Children’s Hospital, Mardis is at the forefront of using genomics for cancer diagnosis and treatment.
Dr. Stephen Quake: A co-president of the Chan Zuckerberg Biohub, Quake’s innovations in genomic technology have accelerated the field of personalized medicine, especially in non-invasive prenatal diagnostics.
